On June 18, 2020, GlaxoSmithKline (GSK) Consumer Healthcare announced a voluntary nationwide recall of two children’s cough and cold products. Two lots of Children’s Robitussin® Honey Cough and Chest Congestion DM (dextromethorphan/guaifenesin) and one lot of Children’s Dimetapp® Cold and Cough (brompheniramine/dextromethorphan/phenylephrine) were recalled at the retail level due to incorrect dosing cups included in the package. The dosing cups had a 20 mL measurement but were missing smaller 5 mL and 10 mL markings. If caregivers do not notice this discrepancy, there is potential for accidental overdose, which may result in symptoms such as impaired coordination, excessive stimulation/sedation, dizziness, or fainting. So far, GSK Consumer Healthcare has not received any reports of adverse events and has notified distributors and retailers to arrange for return of the recalled products.